BATS BZX Real-Time Price
As of 3:47pm ET
| -0.99 / -2.51%|
The 7 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 40.00, with a high estimate of 50.00 and a low estimate of 22.00. The median estimate represents a +3.92% increase from the last price of 38.49.
The current consensus among 7 polled investment analysts is to Hold stock in Clovis Oncology Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.